SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
DATE OF REPORT January 23, 1997
________________________
METRA BIOSYSTEMS, INC.
(Exact name of registrant as specified in its charter)
0-26234
(Commission File Number)
California 33-0408436
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
265 North Whisman Road
Mountain View, CA 94043
(Address of principal executive offices, with zip code)
(415) 903-9100
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS
On January 21, 1997, Metra Biosystems, Inc., a California corporation
(the "Company") announced that the Board of Directors of the Company approved
an amendment of the Company's Preferred Shares Rights Agreement (the "Rights
Agreement") dated as of August 21, 1996 between the Company and The First
National Bank of Boston to increase the ownership threshold required to
trigger the Rights Agreement from 15% to 20%. Further details regarding this
announcement are contained in the Company's press release dated January 21,
1997 attached as an exhibit hereto and incorporated by reference herein.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) EXHIBITS.
Exhibit 99 Metra Biosystems, Inc. Press Release dated January 21, 1997.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
METRA BIOSYSTEMS, INC.
Date: January 23, 1997 By: /s/ KURT E. AMUNDSON
---------------------------------
Kurt E. Amundson
Chief Financial Officer
(Duly Authorized and Principal
Financial and Accounting Officer)
-3-
METRA BIOSYSTEMS, INC.
INDEX TO EXHIBITS
Exhibit Number Description Sequential Page Number
- -------------- ----------- ----------------------
99 Press Release dated January 21, 1997
-4-